Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | H. Jee, Dissertation, 2013, Seoul National University | Link | |
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | G. Maubach et al., EMBO reports, 2021, 22: e52878, DOI10.15252/embr.202152878 | Link | ||
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. V. Rao et al., BMC Cancer, 2017, 17:68, DOI 10.1186/s12885-017-3055-5 | Link | |
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Bhandari et al., Biochem. and Biophys. Res. Commun., 2016, 475: 119-124 | |||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L.-K. M. Selvik et al., PLoS ONE, 2014, 9(11): e112485, doi:10.1371/journal.pone.0112485 | Link | ||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | K. Misund et al., PLoS ONE, 2013, 8(9): e76234, doi:10.1371/journal.pone.0076234 | Link | |||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | T. S. Steigedal et al., In Vitro Cell. Dev.Biol. - Animal, 2013, 49: 162–169, DOI 10.1007/s11626-013-9588-2 | Link | ||
AGS-Gr |
Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | S. Bhandari et al., Biochem. and Biophys. Res. Commun., 2016, 475: 119-124 | |||||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L.-K. M. Selvik et al., PLoS ONE, 2014, 9(11): e112485, doi:10.1371/journal.pone.0112485 | Link | ||
ASC |
Human adipose derived stem cells | Human | other | stem cell | adherent | plasmid | Metafectene PRO | publication | J. Grillari et al., 2015, Patent US9212362B2 | Link | |||
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
BEAS-2B |
Human bronchial epithelial cell line | ATCC CRL-9609 | Human | respiratory system | cell line | adherent | plasmid | K2 Transfection System | publication | P. C. Shivalingappa et al., Antioxidants & Redox Signaling, 2016, 24 (4): 186, DOI: 10.1089/ars.2015.6367 | Link | ||
BEAS-2B |
Human bronchial epithelial cell line | ATCC CRL-9609 | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | C. Maucksch et al., Nucleic Acids Res., Oct 2008; 36: 5462 - 5471 | Link | ||
BON |
pancreatic neuroendocrine tumor cell line | Human | unknown | cell line | siRNA | Metafectene SI | publication | X. Zhang et al., J. Cell Biol., 2017, doi.org/10.1083/jcb.201702099 | Link | ||||
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | E. Crummy et al., J. Biol. Chem., 2019, doi/10.1074/jbc.RA119.007504 | Link | ||
BON |
pancreatic neuroendocrine tumor cell line | Human | unknown | cell line | siRNA | high troughput application | Metafectene SI | publication | X. Zhang et al., J. Cell Biol., 2017, doi.org/10.1083/jcb.201702099 | Link | |||
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. A. Zhang et al., Bio Protoc., 2018, 8 (1): doi:10.21769/BioProtoc.2680 | Link | ||
BT-20 |
Human breast cancer cell line | ATCC HTB-19 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
BTEC |
Human brain glioblastoma endothelial cells | Human | brain | unknown | plasmid | Metafectene PRO | publication | G. Tabatabai et al., Brain, Oct 2008; 131: 2579 - 2595 | Link | ||||
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | Y. Chen et al., Mol. Cancer Res., 2017, 15 (4): 418-28, DOI: 10.1158/1541-7786.MCR-16-0366 | |||
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | A. Carozzoa et al., Mol. Pharmacology, 2019, 115444, DOI: 10.1124/mol.118.115444 | Link | ||
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | A. Carozzoa et al., Mol. Pharmacology, 2019, 115444, DOI: 10.1124/mol.118.115444 | Link | |
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | siRNA | Metafectene PRO | publication | Y. Chen et al., Mol. Cancer Res., 2017, 15 (4): 418-28, DOI: 10.1158/1541-7786.MCR-16-0366 | |||
C4-2 |
Human prostate carcinoma cell line (derivative of LNCaP) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | R.C. Peery, Dissertation,, 2020, Indiana University | Link |